Mark Newman Chemours CO (CC) insider trading activity

Mark Newman is President and CEO of Chemours Co. Currently has a direct ownership of 266,954 shares of CC, which is worth approximately $5.55 Million. The most recent transaction as insider was on Jun 09, 2023, when has been sold 7,661 shares (Common Stock) at a price of $34.63 per share, resulting in proceeds of $265,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 267K

0% 3M change

0% 12M change

Total Value Held $5.55 Million

Mark Newman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2023	BUY Open market or private purchase	$265,300 $34.63 p/Share	7,661 Added 2.79%	266,954 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$182,840 $34.84 p/Share	5,248 Reduced 2.37%	216,118 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	43,053 Added 14.25%	259,171 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$2,437,956 $34.35 p/Share	70,974 Reduced 24.29%	221,250 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	147,540 Added 33.55%	292,224 Common Stock
May 05 2022	SELL Open market or private sale	$7,929,816 $40.22 p/Share	197,161 Reduced 52.79%	176,347 Common Stock
May 05 2022	BUY Exercise of conversion of derivative security	$3,162,463 $16.04 p/Share	197,161 Added 34.55%	373,508 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$32,553 $25.98 p/Share	1,253 Reduced 0.79%	156,623 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	19,630 Added 10.02%	176,253 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$213,990 $30.0 p/Share	7,133 Reduced 4.32%	157,877 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	19,473 Added 10.56%	165,010 Common Stock
Dec 02 2021	SELL Open market or private sale	$1,025,505 $29.94 p/Share	34,252 Reduced 19.06%	145,458 Common Stock
Dec 02 2021	BUY Exercise of conversion of derivative security	$631,949 $18.45 p/Share	34,252 Added 16.01%	179,710 Common Stock
Aug 30 2021	SELL Open market or private sale	$129,185 $35.0 p/Share	3,691 Reduced 2.48%	145,377 Common Stock
Aug 30 2021	BUY Exercise of conversion of derivative security	$68,099 $18.45 p/Share	3,691 Added 2.42%	149,068 Common Stock
Aug 27 2021	SELL Open market or private sale	$1,040,620 $35.0 p/Share	29,732 Reduced 16.98%	145,377 Common Stock
Aug 27 2021	BUY Exercise of conversion of derivative security	$548,555 $18.45 p/Share	29,732 Added 14.51%	175,109 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	3,948 Added 2.64%	145,377 Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	6,247 Added 4.23%	141,271 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$31,054 $26.14 p/Share	1,188 Reduced 0.87%	135,024 Common Stock
Feb 12 2021	BUY Grant, award, or other acquisition	-	2,868 Added 2.06%	136,212 Common Stock

Also insider at

ALTRIA GROUP, INC. Consumer Defensive

Director

Mark Newman

President and CEO

Richmond, VA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CC shares.

Notify only if

Value

Insider Trading

Get notified when an Chemours CO insider buys or sells CC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Chemours Co

Track Activities on CC

Account